Venture Visionary Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.64M | Sell |
35,770
-8,593
| -19% | -$1.6M | 0.25% | 99 |
|
2025
Q1 | $9.3M | Sell |
44,363
-2,322
| -5% | -$487K | 0.39% | 66 |
|
2024
Q4 | $8.3M | Buy |
46,685
+1,917
| +4% | +$341K | 0.35% | 73 |
|
2024
Q3 | $8.84M | Sell |
44,768
-276
| -0.6% | -$54.5K | 0.38% | 74 |
|
2024
Q2 | $7.73M | Buy |
45,044
+687
| +2% | +$118K | 0.36% | 77 |
|
2024
Q1 | $8.08M | Sell |
44,357
-540
| -1% | -$98.3K | 0.38% | 72 |
|
2023
Q4 | $6.96M | Buy |
44,897
+395
| +0.9% | +$61.2K | 0.37% | 77 |
|
2023
Q3 | $6.63M | Sell |
44,502
-479
| -1% | -$71.4K | 0.4% | 69 |
|
2023
Q2 | $6.06M | Buy |
44,981
+987
| +2% | +$133K | 0.36% | 77 |
|
2023
Q1 | $7.01M | Buy |
43,994
+924
| +2% | +$147K | 0.44% | 62 |
|
2022
Q4 | $6.96M | Sell |
43,070
-738
| -2% | -$119K | 0.5% | 50 |
|
2022
Q3 | $5.88M | Buy |
43,808
+1,366
| +3% | +$183K | 0.48% | 53 |
|
2022
Q2 | $6.5M | Buy |
42,442
+809
| +2% | +$124K | 0.49% | 49 |
|
2022
Q1 | $6.75M | Sell |
41,633
-25,232
| -38% | -$4.09M | 0.45% | 58 |
|
2021
Q4 | $9.09M | Buy |
66,865
+3,566
| +6% | +$485K | 0.59% | 43 |
|
2021
Q3 | $6.85M | Buy |
63,299
+4,054
| +7% | +$438K | 0.49% | 50 |
|
2021
Q2 | $6.68M | Buy |
59,245
+3,486
| +6% | +$393K | 0.54% | 40 |
|
2021
Q1 | $6.03M | Buy |
55,759
+21,814
| +64% | +$2.36M | 0.5% | 44 |
|
2020
Q4 | $3.64M | Buy |
33,945
+22,382
| +194% | +$2.4M | 0.4% | 54 |
|
2020
Q3 | $1.05M | Buy |
11,563
+1,888
| +20% | +$171K | 0.26% | 59 |
|
2020
Q2 | $949K | Buy |
9,675
+2,545
| +36% | +$250K | 0.28% | 53 |
|
2020
Q1 | $543K | Buy |
7,130
+3,351
| +89% | +$255K | 0.2% | 74 |
|
2019
Q4 | $334K | Buy |
+3,779
| New | +$334K | 0.1% | 121 |
|